A retroviral vector that directs simultaneous expression of α and β T cell receptor genes

Human Gene Therapy

Volumn 9, Issue 15, 1998, Pages 2299-2304

  Pogulis, Robert J ^a   Pease, Larry R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; VIRUS VECTOR;

ARTICLE; CYTOMEGALOVIRUS; ENHANCER REGION; FLUORESCENCE ACTIVATED CELL SORTER; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HYBRIDOMA; NONHUMAN; PROMOTER REGION; RETROVIRUS; SIGNAL TRANSDUCTION; T LYMPHOCYTE RECEPTOR GENE;

CYTOMEGALOVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0032505704     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.15-2299     Document Type: Article

References (18)

1. CHALLITA, P.-M., and KOHN, D.B. (1994). Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. Proc. Nat. Acad. Sci. U.S.A. 91, 2567-2571.
2. CHIEN, Y., BECKER, D.M., LINDSTEN, T., OKAMURA, M., COHEN, D.I., and DAVIS, M.M. (1984). A third type of murine T-cell receptor gene. Nature (London) 312, 31-35.
3. ETTINGHAUSEN, S.E., and ROSENBERG, S.A. (1995). Immunotherapy and gene therapy of cancer. Adv. Surg. 28, 223-254.
4. HEDRICK, S.M., NIELSEN, E.A., KAVALER, J., COHEN, D.I., and DAVIS, M.M. (1984). Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature (London) 308, 153-158.
5. HONG, S.-C., CHELOUCHE, A., LIN, R., SHAYWITZ, D., BRAUNSTEIN, N.S., GLIMCHER, L., and JANEWAY, C.A. (1992). An MHC interaction site maps to the amino-terminal half of the T cell receptor α chain variable domain. Cell 69, 999-1009.
6. KANG, J., WITHER, J., and HOZUMI, N. (1990). Long-term expression of a T-cell receptor β-chain gene in mice reconstituted with retrovirus-infected hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 87, 9803-9807.
7. LIEU, F.H.L., HAWLEY, T.S., FONG, A.Z.C., and HAWLEY, R.G. (1997). Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: Implications for immune gene therapy. Cancer Gene Ther. 4, 167-175.
8. MANN, R., MULLIGAN, R.C., and BALTIMORE, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153-159.
9. MELIEF, C.J.M., and KAST, W.M. (1995). T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol. Rev. 146, 167-177.
10. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-988.
11. ORCHARD, P.J., DETRICK, R.A., GORDEN, K., DUNBAR, C.E., VALLERA, D.A., TAYLOR, P., MCIVOR, R.S., and BLAZAR, B.R. (1993). Retroviral-mediated transfer of the murine interleukin-3 gene engineered for intracellular retention results in a myoproliferative syndrome but is associated with circulating interleukin-3 levels. Exp. Hematol. 21, 1245-1254.
12. PALMER, T.D., ROSMAN, G.J., OSBORNE, W.R., and MILLER, A.D. (1991). Genetically modified skin fibroblasts persist long after transplantation but gradually inactive introduced genes. Proc. Natl. Acad. Sci. U.S.A. 88, 1330-1334.
13. POGULIS, R.J., JACIR, N.E., and PEASE, L.R. (1995). Polymorphism of the Vα15 T-cell receptor subfamily. Mol. Immunol. 32, 93-95.
14. POGULIS, R.J., VALLEJO, A.N., and PEASE, L.R. (1997). In vitro recombination and mutagenesis by overlap extension PCR. In Methods in Molecular Biology, Vol. 57: In Vitro Mutagenesis Protocols. M.K. Trower, ed. (Humana Press, Totowa, NJ) pp. 167-176.
15. POGULIS, R.J., HANSEN, M.J., and PEASE, L.R. (1998). Retroviral-mediated expression of an MHC class I-restricted T cell receptor in the CD8 T cell compartment of bone marrow-reconstituted mice. Hum. Gene. Ther. 9, 2285-2297.
16. ROONEY, C.M., SMITH, C.A., NG, C.Y.C., LOFTIN, S., LI, C., KRANCE, R.A., BRENNER, M.K., and HESLOP, H.E. (1995). Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet 345, 9-13.
17. SUN, J.-Y., PACHECO-CASTRO, A., BORROTO, A., ALARCON, B., ALVAREZ-ZAPATA, D., and REGUEIRO, J.R. (1997). Construction of retroviral vectors carrying human CD3-γ cDNA and reconstitution of CD3-γ expression and T cell receptor surface expression and function in a CD3-γ-deficient mutant T cell line. Hum. Gene Ther. 8, 1041-1048.
18. ZITVOGEL, L., TAHARA, H., CAI, Q., STORKUS, W.J., MULLER, G., WOLF, S.F., GATELY, M., ROBBINS, P.D., and LOTZE, M.T. (1994). Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum. Gene Ther. 5, 1493-1506.